OncoMed Pharmaceuticals Inc Increase (Decrease) in Accounts Receivable
OncoMed Pharmaceuticals Inc reported Increase (Decrease) in Accounts Receivable of $2.05 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2014-11-04
- OncoMed Pharmaceuticals Inc increase (decrease) in accounts receivable for the quarter ending 2014-09-30 was $2.00M.
- OncoMed Pharmaceuticals Inc increase (decrease) in accounts receivable for the quarter ending 2013-03-31 was -$4.00M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month |
|---|---|---|---|
| 2014-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $2.05M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $48.00K 10-Q · filed 2014-08-07 | ||
| 2013-09-30 | $10.00M 10-Q · filed 2014-11-04 | ||
| 2013-03-31 | -$4.00M 10-Q · filed 2014-05-08 |